These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 15216473

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock.
    Giacometti A, Cirioni O, Ghiselli R, Orlando F, Kamysz W, Rocchi M, D'Amato G, Mocchegiani F, Silvestri C, Łukasiak J, Saba V, Scalise G.
    Peptides; 2005 Feb; 26(2):207-16. PubMed ID: 15629532
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection.
    Cirioni O, Silvestri C, Ghiselli R, Orlando F, Riva A, Mocchegiani F, Chiodi L, Castelletti S, Gabrielli E, Saba V, Scalise G, Giacometti A.
    J Antimicrob Chemother; 2008 Dec; 62(6):1332-8. PubMed ID: 18799470
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain.
    Cirioni O, Ghiselli R, Orlando F, Silvestri C, Mocchegiani F, Rocchi M, Chiodi L, Abbruzzetti A, Saba V, Scalise G, Giacometti A.
    Crit Care Med; 2007 Jul; 35(7):1717-23. PubMed ID: 17452938
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia.
    Ghiselli R, Giacometti A, Cirioni O, Orlando F, Mocchegiani F, Pacci AM, Scalise G, Saba V.
    J Surg Res; 2001 Oct; 100(2):183-8. PubMed ID: 11592790
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis.
    Cirioni O, Giacometti A, Ghiselli R, Kamysz W, Orlando F, Mocchegiani F, Silvestri C, Licci A, Łukasiak J, Saba V, Scalise G.
    J Infect Dis; 2005 Nov 01; 192(9):1613-20. PubMed ID: 16206076
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of the bovine antimicrobial peptide indolicidin combined with piperacillin/tazobactam in experimental rat models of polymicrobial peritonitis.
    Ghiselli R, Giacometti A, Cirioni O, Mocchegiani F, Orlando F, Silvestri C, Di Matteo F, Abbruzzetti A, Scalise G, Saba V.
    Crit Care Med; 2008 Jan 01; 36(1):240-5. PubMed ID: 18090372
    [Abstract] [Full Text] [Related]

  • 11. S-thanatin in vitro prevents colistin resistance and improves its efficacy in an animal model of Pseudomonas aeruginosa sepsis.
    Cirioni O, Wu G, Li L, Orlando F, Silvestri C, Ghiselli R, Shen Z, Gabrielli E, Brescini L, Lezoche G, Provinciali M, Guerrieri M, Giacometti A.
    Peptides; 2011 Apr 01; 32(4):697-701. PubMed ID: 21262298
    [Abstract] [Full Text] [Related]

  • 12. LL-37 protects rats against lethal sepsis caused by gram-negative bacteria.
    Cirioni O, Giacometti A, Ghiselli R, Bergnach C, Orlando F, Silvestri C, Mocchegiani F, Licci A, Skerlavaj B, Rocchi M, Saba V, Zanetti M, Scalise G.
    Antimicrob Agents Chemother; 2006 May 01; 50(5):1672-9. PubMed ID: 16641434
    [Abstract] [Full Text] [Related]

  • 13. Potential therapeutic role of cationic peptides in three experimental models of septic shock.
    Giacometti A, Cirioni O, Ghiselli R, Mocchegiani F, Del Prete MS, Viticchi C, Kamysz W, ŁEmpicka E, Saba V, Scalise G.
    Antimicrob Agents Chemother; 2002 Jul 01; 46(7):2132-6. PubMed ID: 12069965
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis.
    Ghiselli R, Giacometti A, Cirioni O, Dell'Acqua G, Bergnach C, Orlando F, Mocchegiani F, Silvestri C, Skerlavaj B, Licci A, Balaban N, Zanetti M, Scalise G, Saba V.
    Shock; 2006 Sep 01; 26(3):296-301. PubMed ID: 16912656
    [Abstract] [Full Text] [Related]

  • 16. Shrimp (Penaeus monodon) anti-lipopolysaccharide factor reduces the lethality of Pseudomonas aeruginosa sepsis in mice.
    Pan CY, Chao TT, Chen JC, Chen JY, Liu WC, Lin CH, Kuo CM.
    Int Immunopharmacol; 2007 May 01; 7(5):687-700. PubMed ID: 17386416
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Protection against Pseudomonas aeruginosa pneumonia and sepsis-induced lung injury by overexpression of beta-defensin-2 in rats.
    Shu Q, Shi Z, Zhao Z, Chen Z, Yao H, Chen Q, Hoeft A, Stuber F, Fang X.
    Shock; 2006 Oct 01; 26(4):365-71. PubMed ID: 16980883
    [Abstract] [Full Text] [Related]

  • 19. Comparison of in vivo intrinsic activity of cefepime and imipenem in a Pseudomonas aeruginosa rabbit endocarditis model: effect of combination with tobramycin simulating human serum pharmacokinetics.
    Navas D, Caillon J, Gras-Le Guen C, Jacqueline C, Kergueris MF, Bugnon D, Potel G.
    J Antimicrob Chemother; 2004 Oct 01; 54(4):767-71. PubMed ID: 15317741
    [Abstract] [Full Text] [Related]

  • 20. Tachyplesin III and granulocyte-colony stimulating factor enhance the efficacy of tazobactam/piperacillin in a neutropenic mouse model of polymicrobial peritonitis.
    Cirioni O, Ghiselli R, Kamysz W, Orlando F, Silvestri C, Mocchegiani F, Di Matteo F, Kamysz E, Riva A, Rocchi M, Saba V, Scalise G, Giacometti A.
    Peptides; 2008 Jan 01; 29(1):31-8. PubMed ID: 18068869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.